| Name: Phase III NEUPREX(r) Meningococcemia Data Published in The Lancet
Description: Lancet. BerkeleyCA -- September 142000 -- XOMA Ltd. ( Nasdaq: XOMA)a biopharmaceutical company developing products for infectious disease British medical journalThe Lancet..
Category: Lancet Infectious Disease
Url: http://www.xoma.com/news_events/pr_00_09_14.jsp
Date: Oct 7, 2005
Current Rating: 0.00
Clicks/Hits Received: 0 |
|